Services, Equipment & Pricing

Updated: Selleck FDA Approved Drug Library

Received August 2019, the Selleck FDA Approved Drug Library is a collection of 2580 FDA-approved drugs.

• Related to oncology, cardiology, anti-inflammatory, immunology, neuropsychiatry, analgesia, etc.
• Structurally diverse, medicinally active, and cell permeable
• Documented structure, IC50, bioactivity and safety

Selleck Kinase Inhibitor Library

Received November 2013, the Selleck Kinase Inhibitor Library is a unique collection of 273 kinase inhibitors.

• Targets kinases such as RTKs, PI3K, Aurora Kinase, CDK, and MEK
• Most are ATP competitive
• Structurally diverse, medicinally active and cell permeable
• Documented structure, IC50 and customer reviews

Selleck Epigenetics Compound Library

Received April 2015, the Selleck Epigenetics Library is a collection of 128 compounds

• Contains inhibitors of epigenetic enzymes including:
  • Histone Deacetylase (HDACs)
  • SIRTs
  • Lysine demethylases
  • Histone Acetyltransferases (HATs)
  • DNA Methyltransferase (Dnmts)
  • SIRTs activators
• Structurally diverse, medicinally active, and cell permeable

Enzo Screen-Well Bioactive Lipid Library

Received November 2013, the Screen-Well™ Bioactive Lipid Library contains 195 bioactive lipids. This includes:

• Endocannabinoisd
• Farnesyl/geranylgeranly derivatives
• HETEs
• deHETEs
• Hepoxilins
• Polyunsaturated fatty acids
• Leukotrienes
• Lipoxins
• LPA and phosphatidic acids
• Octadecanoids
• PAFs
• Prostaglandins and thromboxanes
• Retinoids
• Vitamin D metabolites
• Sphingolipids

GlaxoSmithKline (GSK) Protein Kinase Inhibitor Set

Received March 2031, July 2014, the Protein Kinase Inhibitor Set (PKIS1 and PKIS2) consists of 868 small molecule kinase inhibitors that have been published by GSK

• Representing a range of chemotypes as well as multiple exemplars within a given chemotype
• Broad coverage of kinase targets, characterized across a panel of 220 kinase assays.

NCI

Received October 2012

• The NCI04 “Diversity Set III” library consists of 1597 compounds.
• The NCI05 “Mechanistic Diversity Set” library consists of 879 compounds which have represent a broad range of structural diversity and patterns of growth inhibition in the NCI 60 cell line screen.
• The NCI06 “Natural Product Set II” library consists of 117 natural products that were selected from the NCI open repository.
• The NCI07 “Approved Oncology Set IV” library includes 101 compounds.

More information about these libraries can be found on the NCI/NIH Developmental Therapeutics Program website for Synthetics and Pure National Products Repositories and Basic Chemical Data.

TimTec Anti-Infectives

Received July 2014, the Anti-Infectives Library includes 960 molecules and contains low molecular weight, drug-like molecules with scaffolds found in antiseptic agents with anti-bacterial (Gram+ve and Gram-ve), anti-fungoid, anti-microbial activities.

Prestwick Chemical Library

Received January 2011, the Prestwick Chemical Library® contains 1280 marketed drugs.

The Spectrum Collection

The Spectrum Library contains 2000 structurally diverse compound selected by medicinal chemists and biologists for a wide range of biological activities

Life Chemicals

(received #1- January 2009, #2- October 2009, #3- November 2015, #4 – October 2016)
The Life Chemicals diversity libraries (LC-1, LC-2, LC-3, LC-4) total 100,000 diverse compounds, arrayed in subsets of 25,000. Each set was selected for diverse coverage of chemical space and general drug-likeness. Available for screening as each subset or the full library.

Maybridge

(received October 2008)
The Maybridge HitFinder collection consists of 14,400 compounds representing the drug-like diversity of the Maybridge compound catalog.

MLPCN: NIH Molecular Libraries Probe Production Centers Network Diversity Library

(received May 2014)
The MLPCN library consists of 340,364 small molecule probes, covering a wide range of chemical space.

NCI NExT Diversity Library

(requested as needed from NCI for oncology-related HTS campaigns that received funding through a peer-viewed process)
The set contains a variety of chemical scaffolds across ten commercial suppliers, while keeping within the boundaries of drug-like chemical space (e.g. Lipinski’s Rule of 5, high QED scores). The collection includes a total of 83,536 compounds.

Tip-less acoustic liquid handling using the Labcyte ECHO can transfer as little as 2.5nL of DMSO compound solution between plates. This capability allows us to offer assay ready plates for screening at low cost. The resulting plates are ready to accept reagents for screening in your lab or ours. Control wells can be formatted as desired. The SMSF Diversity and Specialized libraries are available in 96-well, 384-well and 1536-well formats in a wide range of plate styles. For additional details or prices, please contact Dr. Gene Ananiev (geananiev@wisc.edu).

The Small Molecule Screening Facility (SMSF) offers a broad range of biological profiling assays to help identify a chemical compound’s biological activity and potency including:

• AlphaLisa and AlphaScreen Assays for Biomarkers, Cytokines, Phospho-proteins and more
• AKT Phosphorylation
• Anti-microbial Assays
• Apoptosis Assays
• Cell Migration
• Cytotoxicity and Cell Proliferation Assays
• DNA Damage Assays
• Enzyme Activity
• ERK1/2 Phosphorylation
• HDAC
• NFKb
• Phosphatase Assays (PP1A and PP2A)
• Phosphorylation
• Protein-DNA Binding
• Protein-Protein Binding
• Reporter Gene Expression
• Signal Transduction
• TGF-beta signaling
• Tubulin Polymerization
• Viral Entry
• WNT -Beta Catenin (Super Topflash Assay)
• Wound Healing and Chamber Migration Assays

Custom assay development services are also available.

SMSF is the home of a new Seahorse Bioscience XFe96 Extracellular Flux Analyzer which simultaneously interrogates mitochondrial respiration and glycolysis – in a microplate, in real-time. The XFe96 Analyzer determines in vitro oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) in order to assess cellular functions such as oxidative phosphorylation, glycolysis and fatty acid oxidation.

• Real-time Results- this integrated system reports metabolic rates in just minutes, without sample extraction or labeling. Wave software controls the instrument and performs rate measurements on the fly for same day results.
• Live-Cell Responses – detect responses to substrates, inhibitors, and other compounds in real time via the 4-port injection system and automated mixing while maintaining physiologic temperature (37°C).
• Flexible Assay Design- the 96-well plate format accommodates many conditions in a single run and is best for dose-response studies and compound screening.
• High Sensitivity- analyze as few as 5000 cells per well in the custom 96-well plate. Cell number requirements vary by cell type; consult the Cell Reference Database for details.
• Compatible with a variety of samples due to the precision-controlled heating tray, which can maintain 16-42oC (12oC-20oC above ambient conditions).
• Measure mitochondrial function with the Seahorse XF Cell Mito Stress Test
• Generate a metabolic phenotype within one hour with the Seahorse XF Cell Energy Phenotype Test
• Assess glycolytic rates in live cells with the Seahorse XF Glycolytic Rate Assay
• Quickly determine dependency of cellular energy production on mitochondrial substrates with the Seahorse XF Mito Fuel Flex Test
  Analyze 3D samples such as spheroids and islets with the Seahorse XFe96 Spheroid Plate
• Easily create assay protocols and analyze data with Seahorse Wave software
• For Research Use Only. Not for use in diagnostic procedures.

Mycoplasma contamination is one of the most common and serious problems in culturing eukaryotic cells because it alters the phenotypic characteristics of the cells and can negatively impact results. Since mycoplasma is typically not visible and does not respond to antibiotics, an alternative sensitive and reliable detection method is required. Small Molecule Screening Facility (SMSF) uses the R&D Systems Mycoprobe Mycoplasma Detection Kit. This assay is capable of detecting the eight mycoplasma species known to cause 95% of eukaryotic cell culture contamination: M. hyorhinis, M. arginini, M. fermentans, M. orale, M. pirum, M. hominis, M. salivarium and Acholeplasma laidlawii.

The SMSF staff scientists test each client-provided sample in triplicate along side positive and negative controls.

Assays are usually run the week that samples are submitted and data are available within 48 hours of assay completion.

The SMSF can provide a variety of molecular modeling services to guide the identification of small molecules that bind to protein targets of interest.

Virtual Screening

Homology Modeling

Docking and Scoring

QSAR Modeling

HTS Data Analysis and Compound Selection

Structure-based or Ligand-based molecular design

Protein Molecular Dynamics

We will work with researchers to determine the methods that are most appropriate for each particular project.

Our virtual screening techniques can be applied to most projects where either a protein target or potent ligand is known. Docking and scoring is most commonly applied in conjunction with synthetic chemistry effort.

We are actively involved in optimization of methods for virtual screening and machine learning approaches for drug discovery. We collaborate with investigators from Biostatistics, Computer Science, Engineering, Biochemistry, and the Center for Predictive Computational Phenotyping on these efforts, and use these novel techniques on our discovery projects.

Our computation resources include 5 Dell servers and workstations with a total of 48 CPUs, including NVIDIA 3D graphics capabilities. We make extensive use of computational resources at the UW Center for High Throughput Computing (CHTC) through HTCondor. Common software includes Autodock (Scripps), Vina (Scripps), ROCS and FRED (OpenEye), Sybyl (Tripos), Surflex (UCSF), MOE (CCG). An additional workstation is available for researchers who wish to actively participate under the supervision of our team.

Hands-on Course in Molecular Modeling and Drug Docking

The SMSF also sponsors a “hands on” 8-week course on molecular modeling with an emphasis on drug design called “Molecular Modeling and Drug Docking” for the UW community to learn how to model the drugs in their targets. The course covers the basics of protein and small molecule modeling using the commercial software Sybyl from Tripos. Several docking programs, such as SurFlex, DOCK and Autodock4, are examined with real examples from the literature.

The course is held in the Digital Media Center teaching lab in the Biochemical Sciences Building, 420 Henry Mall. Each student runs Sybyl on a Linux server thru a Macintosh interface. There is no UW credit for this course. The course has been taught the last five years by Dr. Ken Satyshur from the SMSF during the Spring semester.

Preclinical in vitro Pharmacology Assays

The SMSF staff can assist users with characterizing the pharmacological properties of compounds  through contracts maintained with external CROs.

• Aqueous Solubility (pH 5.0,6.2,7.4) Assay
• Lipophilicity, LogD7.4 Assay
• Plasma Stability Assay
• Microsome Stability Assay
• S9 Stability Assay
• Permeability (PAMPA) Assay
• Blood Brain Barrier Permeability (BBB-PAMPA) Assay
• Plasma Protein Binding Assay
• Cytotoxicity (Human Hepatocytes) Assay
• CYP Inhibition (1A2, 2B6, 2C9, 2D6, 3A4) Assay by LC-MS (single conc)
• CYP Inhibition (1A2, 2B6, 2C9, 2D6, 3A4) Assay by LC-MS (dose response)
• Chemical Stability

Preclinical Pharmacokinetics in Mice

The SMSF staff can assist users with obtaining PK results in mice through contracts maintained with external CROs.

• Single compound, 1dose, 1 route, 0.5hr and 2hr
• Brain tissue penetration study, Single compound, 1dose, 1 route, 0.5hr and 2hr
• Single compound, 1dose, 1 routes, 0.5 h, 2h, 4h, and 7h
• Single compound, 1 group, 2 routes, 0, 0.5, 1, 2, 4, 8, 24 hrs
• Five test compounds per mouse, 1dose, 1 route, 0.5hr and 2hr
• Five test compounds per mouse, 1dose, 1 route, 0.5 h, 2h, 4h, and 7h
• Single Dose Tolerability (1 day), Five dose levels, 1 route, 7 Blood sampling times up to 24h post dosing per animal
• Multi- Dose Tolerability (5 days), Five dose levels, 1 route, Animals will receive repeat dose once daily for five days, 7 Blood sampling times up to 24h post dosing per animal